Skip to content

The study on changes in infant skin condition due to the use of a sebum RNA mailing test kit

The study on changes in infant skin condition due to the use of a sebum RNA mailing test kit - The study on changes in infant skin condition due to the use of a sebum RNA mailing test kit

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050694
Enrollment
200
Registered
2023-04-05
Start date
2023-04-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy infants

Interventions

1.Use the skin barrier test &quot
Babiwell Check&quot
and perform skin care based on the test results at one month old. 2.Watch the video and the flyer about skin care at 4 months old. 3.Use the skin barrier test &quot
at 7 months old. 1.Use the skin barrier test &quot
at 7 months old.

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor
Gamagori City Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Persons whose legally authorized representative received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2.Infants aged one month old (intervention group) or 7 months old (non-intervention group) at the time of the preintervention test.

Exclusion criteria

Exclusion criteria: 1.Persons who were judged as inappropriate for study participants by the principal investigators.

Design outcomes

Primary

MeasureTime frame
Changes in skin condition based on UKWP (The U.K. Working Party) at 7 months old

Secondary

MeasureTime frame
1. Relationship between sebum RNA and skin conditions at one month old and 7 months old 2. Relationship between sebum RNA and questionnaire at one month old and 7 months old

Countries

Japan

Contacts

Public ContactYuki Asahina

Healthcare Systems Co., Ltd. Clinical Research Department

asahina.yuki@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026